Medium | P30876 | DNA-directed RNA polymerase II subunit RPB2 OS=Homo sapiens OX=9606 GN=POLR2B PE=1 SV=1 | 0.014 | 1.714 | 1 | 1 | 1 | 1 | 1174 | 133.8 | 6.87 | 1 | | | | 1 | | | | | | | | | | | | | metabolic process;regulation of biological process;response to stimulus | membrane;nucleus | catalytic activity;DNA binding;metal ion binding;protein binding;RNA binding | "Pf00562, Pf04560, Pf04561, Pf04563, Pf04565, Pf04566, Pf04567" | 5431 | ENSG00000047315.15 | POLR2B | 4 | Signaling by FGFR2 IIIa TM; RNA polymerase II transcribes snRNA genes; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Formation of HIV-1 elongation complex containing HIV-1 Tat; MicroRNA (miRNA) biogenesis; Formation of the HIV-1 Early Elongation Complex; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; TP53 Regulates Transcription of DNA Repair Genes; Transcriptional regulation by small RNAs; HIV Transcription Initiation; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events; RNA Polymerase II HIV Promoter Escape; Formation of HIV elongation complex in the absence of HIV Tat; Transcriptional regulation of pluripotent stem cells; Gap-filling DNA repair synthesis and ligation in TC-NER; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; Formation of TC-NER Pre-Incision Complex; Pausing and recovery of HIV elongation; RNA Polymerase II Promoter Escape; HIV elongation arrest and recovery; RNA Pol II CTD phosphorylation and interaction with CE; Viral Messenger RNA Synthesis; RNA Polymerase II Transcription Initiation; mRNA Capping; Dual incision in TC-NER; PIWI-interacting RNA (piRNA) biogenesis; Pausing and recovery of Tat-mediated HIV elongation; Formation of the Early Elongation Complex | Epstein-Barr virus infection; Huntington's disease; Purine metabolism; RNA polymerase; Metabolic pathways; Pyrimidine metabolism | 0 |